RxDoctor Payments Data

Sandrine Lebrun, MD

Interventional Cardiology · New York, NYNPI 1538541917

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,182 of the $6,309 with a category attached, or 82.1%. It is spread thinly across 13 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $4,760 and has fallen 96.1% since, to $187 in 2025. That places this record below the midpoint for interventional cardiology clinicians in NY, where the typical reported total is $8,047.

$6,309in general payments, 2019–2025

Across 86 payments — averaging $73.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Shockwave Medical, Inc$1K
  • Boston Scientific$1K
  • Abbott$1K
  • Abiomed$798
  • Medtronic$565
  • Cardiovascular Systems Inc.$309
  • plus $629 from 7 others

What the payments were for

  • Grants$1,12618%
  • Food & beverage$5,18282%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,309 in reported general payments places this provider in the 40th percentile of 382 interventional cardiology providers in New York.

See all interventional cardiology providers in New York →

Medicare billing

Part B allowed, 2024
$126,301
Medicare patients
485
Services billed
1,169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →